Dr Tamara Bininashvili, MD in Salem, OR - Medicare Internal Medicine

Dr Tamara Bininashvili, MD is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Salem, Oregon. She graduated from medical school in 2013 and has 11 years of diverse experience with area of expertise as Internal Medicine. She is a member of the group practice Oregon Oncology Specialists Llp and her current practice location is 3025 Ryan Dr Se, Salem, Oregon. You can reach out to her office (for appointments etc.) via phone at (503) 540-9999.

Dr Tamara Bininashvili is licensed to practice in Oregon (license number MD192737) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1225455686.

Contact Information

	Dr Tamara Bininashvili, MD
	3025 Ryan Dr Se, Salem, OR 97301-5057
	(503) 540-9999
	(503) 540-3105

Physician's Profile

Full Name	Dr Tamara Bininashvili
Gender	Female
Speciality	Internal Medicine
Experience	11 Years
Location	3025 Ryan Dr Se, Salem, Oregon
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Tamara Bininashvili graduated from medical school in 2013

NPI Data:

NPI Number: 1225455686
Provider Enumeration Date: 03/24/2014
Last Update Date: 02/28/2024

Medicare PECOS Information:

PECOS PAC ID: 2466763982
Enrollment ID: I20190820004303

Medical Identifiers

Medical identifiers for Dr Tamara Bininashvili such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1225455686	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RI0200X	Internal Medicine - Infectious Disease	MD192737 (Oregon)	Primary
207RI0200X	Internal Medicine - Infectious Disease	A147439 (California)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Secondary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Salem Hospital	Salem, OR	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Oregon Oncology Specialists Llp	3971576240	38

News Archive

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use.

First indication that Parkinson's disease can be caused by a defect in a protein

The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.

Father's age shown to affect health of offspring

A new study has shown that infants of older fathers are less likely to be healthy at birth, compared with infants of younger fathers.

Reports examine progress in global NTD response

Writing in the ONE Blog, Neeraj Mistry, managing director of the Global Network for Neglected Tropical Diseases, highlights two reports released last week that examine global efforts against neglected tropical diseases (NTDs) one year after the London Declaration, as well as a report by the Hudson Institute, also released last week, which "highlight[s] the crucial links between NTDs and broader economic and societal consequences."

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Tamara Bininashvili allows following entities to bill medicare on her behalf.

Entity Name	Oregon Oncology Specialists Llp
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1013953025 PECOS PAC ID: 3971576240 Enrollment ID: O20040816000322

News Archive

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use.

First indication that Parkinson's disease can be caused by a defect in a protein

The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

Father's age shown to affect health of offspring

A new study has shown that infants of older fathers are less likely to be healthy at birth, compared with infants of younger fathers.

Reports examine progress in global NTD response

Entity Name	Cascade Infectious Diseases And Infusion Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1639403330 PECOS PAC ID: 0143356360 Enrollment ID: O20100326000893

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use.

First indication that Parkinson's disease can be caused by a defect in a protein

The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

Father's age shown to affect health of offspring

A new study has shown that infants of older fathers are less likely to be healthy at birth, compared with infants of younger fathers.

Reports examine progress in global NTD response

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Tamara Bininashvili is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Tamara Bininashvili, MD 875 Oak St Se Ste 4030, Salem, OR 97301-3984 Ph: (503) 561-6444	Dr Tamara Bininashvili, MD 3025 Ryan Dr Se, Salem, OR 97301-5057 Ph: (503) 540-9999

News Archive

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use.

First indication that Parkinson's disease can be caused by a defect in a protein

The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson's disease and early menopause.

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

Father's age shown to affect health of offspring

A new study has shown that infants of older fathers are less likely to be healthy at birth, compared with infants of younger fathers.

Reports examine progress in global NTD response

Internal Medicine Doctors in Salem, OR

Dr. Andrew P. Hope, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se, Suite 4000, Salem, OR 97301 Phone: 503-364-0189 Fax: 503-364-9288
Brett W Mikeska, M D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se Ste 5070, Salem, OR 97301 Phone: 503-561-8565 Fax: 503-561-8560
Dr. Aneet Jyot Deo, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se Ste 5070, Salem, OR 97301 Phone: 503-561-8565 Fax: 503-561-8560
Joseph J Thaler, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5050 Skyline Village Loop S, Salem, OR 97306 Phone: 503-391-1110 Fax: 503-370-4237
Dr. Krystyna Antonina Pekalska, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2400 Lancaster Dr Ne, Salem, OR 97305 Phone: 503-361-5400
Dr. Falguny I Bhavan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se, Ste 3010, Salem, OR 97301 Phone: 503-399-7520 Fax: 503-362-7344
Dr. Douglas Michael Carney, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 960 Liberty St Se Ste 140, Salem, OR 97302 Phone: 503-540-0304 Fax: 503-540-0305

Dr Tamara Bininashvili, MD - Medicare Internal Medicine in Salem, OR

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

First indication that Parkinson's disease can be caused by a defect in a protein

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

Father's age shown to affect health of offspring

Reports examine progress in global NTD response

Medicare Reassignments

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

First indication that Parkinson's disease can be caused by a defect in a protein

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

Father's age shown to affect health of offspring

Reports examine progress in global NTD response

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

First indication that Parkinson's disease can be caused by a defect in a protein

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

Father's age shown to affect health of offspring

Reports examine progress in global NTD response

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

First indication that Parkinson's disease can be caused by a defect in a protein

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

Father's age shown to affect health of offspring

Reports examine progress in global NTD response

Internal Medicine Doctors in Salem, OR